Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4501
Mitsubishi UFJ Financial
MUFG
$254B
| $168K | ﹤0.01% |
26,159
-9,264
| -26% | -$58.5K |
|
4502
Syndax Pharmaceuticals
SNDX
$1.76B
| $168K | ﹤0.01% |
14,404
+9,360
| +186% | +$115K |
|
4503
PUT
W.P. Carey
WPC
$16.4B
| $168K | ﹤0.01% |
2,553
+1,021
| +67% | +$67.9K |
|
|
MFGP
4504
PUT
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $168K | ﹤0.01% |
+4,340
| New | +$168K |
|
4505
Dana Inc
DAN
$2.94B
| $167K | ﹤0.01% |
6,009
-11,514
| -66% | -$279K |
|
4506
CALL
Frontline
FRO
$8.81B
| $167K | ﹤0.01% |
27,700
+18,000
| +186% | +$102K |
|
4507
Ormat Technologies
ORA
$6.6B
| $167K | ﹤0.01% |
2,738
-1,111
| -29% | -$64.1K |
|
4508
Seacoast Banking Corp of Florida
SBCF
$3.34B
| $167K | ﹤0.01% |
6,995
+4,742
| +210% | +$110K |
|
4509
PUT
Air Products & Chemicals
APD
$66.8B
| $166K | ﹤0.01% |
1,100
+100
| +10% | +$14.7K |
|
4510
CALL
BioCryst Pharmaceuticals
BCRX
$2.36B
| $166K | ﹤0.01% |
31,700
-98,200
| -76% | -$503K |
|
4511
iShares MSCI Australia ETF
EWA
$1.44B
| $166K | ﹤0.01% |
7,403
-3,458
| -32% | -$77.8K |
|
|
OPB
4512
DELISTED
Opus Bank Common Stock
OPB
| $166K | ﹤0.01% |
6,880
-3,442
| -33% | -$79.7K |
|
4513
Adeia
ADEA
$3.12B
| $165K | ﹤0.01% |
24,593
-60,703
| -71% | -$447K |
|
4514
Lindsay Corp
LNN
$1.17B
| $165K | ﹤0.01% |
1,798
+129
| +8% | +$11.5K |
|
4515
abrdn Physical Gold Shares ETF
SGOL
$7.25B
| $165K | ﹤0.01% |
13,300
| – | – |
|
4516
PUT
Zillow
ZG
$7.72B
| $165K | ﹤0.01% |
4,100
+1,800
| +78% | +$76.1K |
|
|
GLUU
4517
PUT
DELISTED
Glu Mobile Inc.
GLUU
| $165K | ﹤0.01% |
43,800
+31,900
| +268% | +$100K |
|
|
HCR
4518
PUT
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $165K | ﹤0.01% |
17,400
-2,800
| -14% | -$24.6K |
|
|
CAVM
4519
PUT
DELISTED
Cavium, Inc.
CAVM
| $165K | ﹤0.01% |
2,500
+800
| +47% | +$50.6K |
|
4520
iShares MSCI Malaysia ETF
EWM
$325M
| $164K | ﹤0.01% |
5,051
| – | – |
|
|
ZAGG
4521
PUT
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $164K | ﹤0.01% |
+10,400
| New | +$114K |
|
4522
Ambev
ABEV
$46.5B
| $163K | ﹤0.01% |
24,838
-76,289
| -75% | -$473K |
|
4523
LiveRamp
RAMP
$2.3B
| $163K | ﹤0.01% |
6,625
-735
| -10% | -$18K |
|
|
VRN
4524
DELISTED
Veren
VRN
| $163K | ﹤0.01% |
20,291
+2,000
| +11% | +$14.6K |
|
|
CTLT
4525
DELISTED
CATALENT, INC.
CTLT
| $163K | ﹤0.01% |
4,083
-992
| -20% | -$36.7K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.